PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCERS

The present invention relates to a pharmaceutical composition and the like for treating and/or preventing cancer, said pharmaceutical composition containing the following as active ingredients: an MRAP2 protein comprising an amino acid sequence represented by SEQ ID NO. 2, 4, 6 or 8 or an amino acid...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Okano, Fumiyoshi, Fujita, Takayuki
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a pharmaceutical composition and the like for treating and/or preventing cancer, said pharmaceutical composition containing the following as active ingredients: an MRAP2 protein comprising an amino acid sequence represented by SEQ ID NO. 2, 4, 6 or 8 or an amino acid sequence having at least 80% sequence identity with these amino acid sequences, or a fragment of said MRAP2 protein containing 7 or more continuous amino acids; and an antibody having immunological reactivity or a fragment thereof.